Equities

Synektik SA

Synektik SA

Actions
Health CareHealth Care Providers
  • Price (PLN)174.80
  • Today's Change2.00 / 1.16%
  • Shares traded7.63k
  • 1 Year change+138.15%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Synektik SA is a Poland-based company active in the medical sector. It produces PACS software which allows running a diagnostic imaging laboratory. It runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The Company sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.

  • Revenue in PLN (TTM)624.80m
  • Net income in PLN84.64m
  • Incorporated2011
  • Employees164.00
  • Location
    Synektik SAul. Jozefa Piusa Dziekonskiego 3WARSZAWA 00-728PolandPOL
  • Phone+48 223270900
  • Fax+48 228498055
  • Websitehttps://www.synektik.com.pl/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Detection Technology Oyj-434.36bn-434.36bn884.87m464.00--2.76----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
BICO Group AB844.46m-294.99m896.57m828.00--0.8285--1.06-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Onward Medical NV0.00-152.68m903.34m99.00--7.67-----1.09-1.090.000.60790.00----0.00-66.40-55.70-79.20-61.60-------79,513.95----0.4855---34.62---10.40--32.59--
Medistim ASA204.91m38.07m968.41m152.0025.416.3720.424.735.555.5529.8722.121.130.74617.483,599,204.0021.0522.9325.5328.5279.1278.2518.5820.642.75--0.018175.257.0010.06-8.9112.720.03314.87
Tristel Plc218.91m33.88m1.10bn213.0032.606.4522.815.000.1350.1350.87140.68180.98121.815.74--15.189.3217.7510.7680.0880.7515.4711.093.04--0.1532109.3516.459.8945.469.9910.1319.53
Nyxoah SA22.07m-230.13m1.18bn147.00--2.59--53.41-1.72-1.720.1663.040.03660.55692.3034,618.53-38.20-23.73-42.88-25.9861.7562.42-1,042.52-1,469.594.95-45.270.1822--40.99---38.39--100.58--
COLTENE Holding AG1.12bn57.72m1.40bn1.19k24.353.0015.621.262.062.0639.8916.731.271.386.06198,668.906.5510.4811.7018.7464.9062.685.177.470.861910.180.342179.94-9.133.54-54.05-6.81-7.72-7.79
Guerbet SA3.59bn142.31m1.44bn2.92k10.480.85333.720.40242.512.5166.4230.820.81280.54935.56282,958.603.031.404.961.8678.5876.023.731.821.163.850.507357.824.30-0.0993158.05-12.615.23-10.07
Stratec SE1.09bn43.49m1.46bn1.46k33.631.4811.501.340.82360.823620.6118.740.56051.275.32164,609.702.247.072.858.2027.0427.324.009.700.92693.860.401140.81-4.636.88-55.293.30-2.16-7.68
Synektik SA624.80m84.64m1.49bn164.0017.627.7615.252.399.929.9273.2522.521.8426.956.41--24.9815.0939.9723.8326.8224.8813.5511.001.4945.180.109--39.8235.9061.3656.0850.89--
IVF Hartmann Holding AG715.05m82.48m1.64bn298.0019.862.4814.962.297.357.3563.7258.840.87883.148.52502,947.4010.147.2912.068.9055.2153.2911.548.303.95--0.005852.16-1.792.0934.951.49-14.8326.82
medmix AG2.24bn-8.42m1.67bn2.70k--0.76466.190.7432-0.05-0.0511.3511.300.47783.405.58180,474.00-0.09962.06-0.12272.4932.5836.38-0.20854.161.062.210.436167.701.991.40-97.41-64.3612.01--
Ion Beam Applications SA2.02bn34.10m1.74bn1.84k49.104.2720.390.85820.26890.268915.993.090.77212.152.70234,517.101.301.556.014.3234.1935.231.692.380.63723.770.399264.8318.6710.74-250.40---8.06--
CellaVision AB276.37m56.32m1.92bn228.0034.066.6626.676.946.306.3030.9132.190.78491.917.263,233,162.0015.9915.3018.4518.2466.9969.0320.3819.982.151,358.860.044110.185.9413.1710.128.0030.458.45
RaySearch Laboratories AB (publ)438.28m65.63m1.99bn414.0039.118.4412.774.555.105.1034.0923.650.60235.513.293,005,152.009.021.2913.691.8891.0690.5714.972.551.27108.610.370669.0021.1610.26243.060.7648-1.31--
Data as of Nov 21 2024. Currency figures normalised to Synektik SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

7.73%Per cent of shares held by top holders
HolderShares% Held
Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 31 Dec 2023221.47k2.60%
Generali PTE SAas of 29 Dec 2023173.55k2.04%
Norges Bank Investment Managementas of 30 Jun 2024147.76k1.73%
Dimensional Fund Advisors LPas of 07 Nov 202451.13k0.60%
Discover Capital GmbHas of 30 Jun 202420.00k0.23%
ICM InvestmentBank AGas of 30 Aug 202420.00k0.23%
Victory Capital Management, Inc. (Investment Management)as of 30 Sep 20249.99k0.12%
RAM Active Investments SAas of 30 Jun 20245.82k0.07%
Apo Asset Management GmbHas of 31 Mar 20245.50k0.06%
mTFI SAas of 30 Jun 20234.51k0.05%
More ▼
Data from 30 Jun 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.